Clinical Trials in Baltimore

Showing 18801-18820 of 23,476 trials

Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

NCT01221441

The purpose of this study is to see if we can safely regenerate cartilage without invasive surgery using a biologic product called TissueGene-C.

Osteoarthritis, Knee

Kolon TissueGene, Inc.102 participantsStarted May 2011

Pinellas Park, Florida, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NCT00892437

The objective of this study is to evaluate the safety and efficacy of a regimen containing cobicistat-boosted atazanavir (ATV+COBI) plus emtricitabine/tenofovir disoproxil fumarate (Truvada®; FTC/TDF) versus ritonavir-boosted atazanavir (ATV+RTV) plus FTC/TDF in HIV-1 infected, antiretroviral treatment-naive adults. Participants will be randomized in a 2:1 ratio. Randomization will be stratified by HIV-1 RNA level (≤ 100,000 copies/mL or \> 100,000 copies/mL) at screening. After Week 48, participants will continue to take their blinded study drug and attend visits every 12 weeks until treatment assignments are unblinded, at which point all participants will return for an unblinding visit and be given the option to participate in an open-label rollover extension and receive ATV+COBI+FTC/TDF until COBI tablets become commercially available, or until Gilead Sciences elects to terminate the study.

HIV-1 Infection

Gilead Sciences85 participantsStarted May 2009

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +28 more locations

Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Find Trials by Condition in Baltimore

Cerebral Blood Flow During CPB During Cardiac Surgery and the Presence of Post op Delirium

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Thera-Band® HEP for LBP Secondary Prevention

Cramer Sports Motion Tape and Low Back Pain EMG

Permeability Factor in Focal Segmental Glomerulosclerosis

Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

Internet and Telephone Counseling for Smoking Cessation

Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

Relapse Prevention Study in Newly Abstinent Smokers

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

A Novel Diet-Phenotype Interaction Affecting Body Weight

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)